Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

GE Healthcare Announces Agreement with Research Group at Karolinska Institutet, Sweden to Provide Next Generation Sequencing Services

September 27, 2013 By Business Wire

GE Healthcare (GEHC), a unit of GE (NYSE: GE) announced today that it has won a tender to exclusively provide next generation sequencing services to a research group at Karolinska Institutet in Sweden. The sequencing services will be provided by a subsidiary of GE Healthcare, SeqWright Genomic Services, a Houston, Texas-based provider of nucleic acid sequencing and other genomic services.

The first clinical study using the “next generation” sequencing technology will focus on identifying mutations and genetic variants associated with metastatic breast cancer. The large, cohort study will be conducted using tissue samples provided by Karolinska Institutet and analysed using GE Healthcare’s next generation sequencing (NGS) capabilities. Combining GEHC’s current diagnostic capabilities with molecular diagnostics and genomics is GEHC’s vision of precision diagnostics for better patient care.

“Understanding how genetic variations at the molecular level affect disease is critical to the discovery and development of new and more effective therapies for complex diseases such metastatic breast cancer,” said Ger Brophy, Chief Technology Officer Life Sciences, GE Healthcare,. “While antibody-based analysis of biomarkers are the cornerstone to diagnosing breast cancer, uncovering the broader molecular landscape of complex cancers using genome-wide screening tools such as NGS, will be critical to the future of therapeutic decision making and new therapeutic development.” Breast cancer is the most common invasive cancer in women worldwide and is currently treated by a combination of surgery, radiation therapy and chemotherapy. The treatment decision is based on several clinical factors and histopathological analysis. However, it is currently not always possible to predict which patient will relapse with metastatic disease. Therefore, new predictive markers for metastatic disease are needed and genome wide-screening through technologies like NGS may aid in their discovery.

In 2010, GE Healthcare acquired Clarient Diagnostic Services, a leading player in the fast-growing molecular diagnostics sector specializing in innovative services and diagnostic technologies for the assessment and characterization of cancer. In 2012, GE Healthcare acquired SeqWright, Inc., a provider of nucleic acid sequencing and other genomic services to further add genomics capabilities to Clarient.

The combination of these two businesses places GE Healthcare in a position to apply the power of next- and third-generation DNA sequencing technology to the development of clinical and companion diagnostics, potentially revolutionizing the way healthcare decisions are made.

In September 2011, GE Healthcare announced it would dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.

Related Articles Read More >

Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech